临床表现 临床表现
Kaela A Franco1, Joel Ramirez2,3, Fuqiang Gao2
1Dr. Sandra Black Centre for Brain Resilience and Recovery, Sunnybrook Research Institute, Toronto, ON, Canada.
Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 24, 2025
概括
神经退行性疾病中的海马缩与增加的冷漠,异常行为和更差的睡眠质量有关. 这些发现凸显了海马在情绪调节和睡眠中的作用,表明了对大脑缩的反应补偿机制.
科学领域:
- 神经科学是一个神经科学.
- 神经学 神经学
- 睡眠医学 睡眠医学
背景情况:
- 导致痴呆的神经退行性疾病与海马缩有关,导致认知能力下降和情绪失调.
- 海马对于记忆巩固和情绪调节至关重要,特别是情绪记忆的情节性记忆.
- 行为症状 (冷漠,异常行为) 和睡眠质量是痴呆症的关键问题,由神经精神病学库存 (NPI) 和匹兹堡睡眠质量指数 (PSQI) 评估.
研究的目的:
- 在患有神经退行性疾病的患者中调查海马体积与神经精神病学库存 (NPI) 和匹兹堡睡眠质量指数 (PSQI) 的得分之间的相关性.
- 了解海马缩和行为症状 (如冷漠和异常行为) 之间的关系.
- 探索海马体积和主观睡眠质量之间的关联.
主要方法:
- 来自桑尼布鲁克痴呆症研究 (SDS) 和安大略省神经退行性疾病研究计划 (ONDRI) 的回顾性数据分析.
- 标准化神经成像管道 (HippMapp3r) 来测量海马缩;全脑缩小 (BPF) 和白质高强度体积 (WMH) 也被评估.
- 使用线性回归和相关性分析来检查关联,对年龄,性别,教育,BPF和WMH进行控制.
主要成果:
- 在SDS队列中,海马体积与NPI-Aberrant评分 (p=0.029) 和NPI-Apathy评分 (p=0.007) 有负相关性.
- 在ONDRI队列中,海马体积与阿尔茨海默病/轻度认知障碍 (ADMCI) 和脑血管疾病 (CVD) 组的睡眠质量差 (PSQI) 相对相关 (分别p<0.0001和p=0.002).
- 在ADMCI组中,较小的海马体积与更长的睡眠时间有关 (p<0.0001).
结论:
- 神经退行性疾病中的海马缩可能导致冷漠性增加,异常行为和睡眠模式改变.
- 降低海马体积可能会损害情绪调节,并触发补偿性睡眠质量机制.
- 未来的研究应该包括客观的睡眠测量和全面的行为评估,以进一步阐明这些关系.
相关概念视频
Chronic Kidney Disease II: Clinical Manifestations
520
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
520
Coronary Artery Disease III: Clinical Manifestations
299
Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
299
Endocarditis II: Clinical Features of Infective Endocarditis
364
Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
364
Heart Failure III: Clinical Manifestations
436
Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
436
Gastroesophageal Reflux Disease II: Clinical Features and Management
652
Gastroesophageal reflux disease, or GERD, is a persistent medical condition that affects many individuals worldwide. Its clinical manifestations can vary greatly, making diagnosis and management challenging for healthcare professionals. The following is a comprehensive overview of the clinical manifestations, assessment, and management strategies for GERD.
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
652
Hypertension III: Clinical Manifestations and Diagnostic Studies
437
Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
437


